Viewing Study NCT07327034


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-30 @ 2:30 AM
Study NCT ID: NCT07327034
Status: RECRUITING
Last Update Posted: 2026-01-08
First Post: 2025-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCC View
None FGF19 overexpression View
None ABSK-011 View